René Bernards
Net worth: 156 250 $ as of 2026-05-30
Net worth: 156 250 $ as of 2026-05-30
René Bernards was the founder of Agendia, Inc. (founded in 2003, Chief Scientific Officer since 2010) and Agendia NV (founded in 2003, Chief Scientific Officer from 2009 to 2010).
Dr. Bernards is currently a Director at the American Association for Cancer Research (since 2018), a Professor-Molecular Carcinogenesis at the University of Utrecht, a Member of The Royal Netherlands Academy of Arts & Sciences, the Head of the Molecular Carcinogenesis Division at Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, and an Operational Partner at Gilde Healthcare Partners, Inc. Formerly, Independent Director at Lixte Biotechnology Holdings, Inc. from 2022 to 2025.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-29 | 25,000 ( 0.2% ) | 156 250 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Founder | 2002-12-31 |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Director/Board Member | 2017-12-31 |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
| Companies | Position | End |
|---|---|---|
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director/Board Member | 2025-08-31 |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 2020-01-07 |
| ░░░░░░░ ░░ | ░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Royal Netherlands Academy of Arts & Sciences
The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Provides research services in the field on science and art | Commercial Services |
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. BiotechnologyHealth Technology Develops diagnostics, medication and treatments for various forms of cancer | Health Technology |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Select your edition
All financial news and data tailored to specific country editions